Effect of Topiramate on body weight of patients with schizophrenia treated with Olanzapine
Not Applicable
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT201402085280N15
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
The inclusion criteria included: Schizophrenia according to DSM-IV-IR; aged between 18-60 years.
Exclusion criteria included: Substance abuse in the past six months, a history of seizures, concomitant use of other drugs except benzodiazepines and beta-blockers .
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight. Timepoint: 0,1,2,4,6,8,12 weeks. Method of measurement: Balance.;Around the wrist. Timepoint: 0,4,8,12 weeks. Method of measurement: Meter.;Waist. Timepoint: 0,4,8,12 weeks. Method of measurement: meter.
- Secondary Outcome Measures
Name Time Method Clinical tests (FBS,UREA, TG, SGOT,SGPT,Cholestrol). Timepoint: Baseline and end of plan. Method of measurement: in Laboratory.